TrialOncotarget2016

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer.

Line S Tarpgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.